We have previously demonstrated that glutamate (Glu) suppresses cellular proliferation toward self-renewal through a mechanism associated with the depletion of intracellular GSH after promoting the retrograde operation of the bidirectional cystine/Glu antiporter in undifferentiated osteoblastic MC3T3-E1 cells. In this study, we investigated the expression profile of the xCT subunit of the antiporter as well as the master regulator of osteoblastogenesis runt-related transcription factor-2 (Runx2) in ovariectomized mouse bone. In spinal columns isolated 28 days after ovariectomy, a marked reduction was seen with the intensity of Von Kossa staining used as an index of ossification. In femurs of these ovariectomized mice, a significant decrease was seen in mRNA and protein levels of Runx2 along with increased expression of both mRNA and the corresponding protein for the xCT subunit. To evaluate the possible role of the antiporter in osteoblastogenesis, stable transfectants were established with the xCT subunit toward the culture with osteoblastic differentiation inducers in MC3T3-E1 cells. In stable xCT transfectants cultured under differentiation conditions, marked decreases were seen in nodule formation, Ca 2+ accumulation, and osteoblastic marker gene expression, in addition to downregulation of both mRNA and the corresponding protein for Runx2. Runx2 promoter activity was markedly stimulated in MC3T3-E1 cells transfected with a responsive promoter plasmid after the culture under differentiation conditions, while transient and stable transfection with xCT expression vector invariably prevented the stimulation through an activator protein-1 site. These results suggest that Runx2 expression would be negatively regulated by the cystine/glutamate antiporter expressed by osteoblastic cells at the level of gene transactivation.
Introduction
Bone formation and remodeling are tightly regulated by the delicate balancing between bone-forming osteoblasts and bone-resorbing osteoclasts (1 -3) . The development and differentiation of these two distinct cells are under the control by a number of endogenous substances. These include growth factors, cytokines, hormones, and amino acids, which are individually secreted through endocrine, paracrine/autocrine, and neurocrine systems essential for the maintenance of negative and positive regulations between bone formation and resorption by the two different cells enriched in bone marrow microenvironment toward bone remodeling. An imbalance between these two cells leads to the pathogenesis and etiology of certain bone metabolic diseases, such as osteoporosis and osteopetrosis (4, 5) .
Several transcription factors are identified as a key player for the regulation of cell differentiation and function in osteoblasts. These include runt-related transcrip-tion factor-2 (Runx2) (also referred to as core binding factor alpha-1, Cbfa1) (6, 7) and osterix (8, 9) . In particular, the master regulator of osteoblastogenesis Runx2 is a cell-specific member of the Runt family of transcription factors, with a critical role in cellular differentiation processes in osteoblasts. For instance, Runx2 is the most specific and crucial molecular marker of the osteoblast lineage during cellular maturation among different transcription factors identified to date (6 -8, 10 ). Runx2 expression is indispensable and sufficient to induce osteoblastic differentiation for subsequent regulation of expression of a variety of genes characteristic to the osteoblast phenotype, including osteocalcin, osteopontin, and type I collagen.
The cystine/glutamate (Glu) antiporter (Xc − ) is a sodium-independent and chloride-dependent high affinity carrier, with expression profiles in a variety of different tissues (11, 12) . This antiporter is a heterodimeric complex between the abundant CD98 heavy chain, also referred to as 4F2hc, and the xCT light chain responsible for determination of the substrate specificity (12) . The bidirectional antiporter Xc − is believed to be a crucial determinant of intracellular levels of reduced glutathione (GSH), which is an important endogenous antioxidant (13, 14) , through the anterograde transport of extracellular cystine across plasma membranes to fuel the substrate cysteine in exchange for intracellular Glu in a variety of eukaryotic cells (15, 16) .
In our previous study, cellular proliferation is markedly suppressed by Glu through a mechanism relevant to the retrograde operation of the antiporter Xc − in MC3T3-E1 cells cultured in the absence of differentiation inducers (17) . In this study, therefore, we have attempted to evaluate the possible correlation between the master regulator of osteoblastogenesis Runx2 and the antiporter xCT subunit to further elucidate the possible role of the antiporter Xc − in osteoblastogenesis using in vivo and in vitro experimental techniques.
Materials and Methods

Materials
Std-ddY mice were supplied by Sankyo Labo Service (Tokyo). Pre-osteoblastic MC3T3-E1 cells were purchased from RIKEN Cell Bank (Saitama). Bovine insulin and anti β-tubulin antibody were purchased from Sigma (St. Louis, MO, USA). Alpha minimal essential medium (αMEM) was obtained from Gibco BRL (Grand Island, NY, USA). Taq polymerase was obtained from Takara (Tokyo). The dual luciferase assay system was purchased from Promega (Madison, WI, USA). M-MLV Reverse Transcriptase, Lipofectamine reagent, Plus reagent, Alexa Fluio 488 goat anti-mouse IgG, and Alexa Fluio 594 goat anti-rabbit IgG were supplied by Invitrogen Corp. (Carlsbad, CA, USA). Anti-Runx2 antibody was purchased from MBL (Aichi). Anti-xCT antibody was purchased from ABR (Golden, CO, USA). Both anti-rabbit IgG and anti-mouse IgG were purchased from Santa Cruz (Santa Cruz, CA, USA). Both C-TEST kit and ISOGEN were obtained from Wako (Osaka). Luciferase reporter plasmids with 7 tandem copies of activator protein-1 (AP-1) response element (pAP-1-Luc) and 4 tandem copies of cAMP response element (CRE) (pCRELuc) were purchased from Stratagene (Santa Clara, CA, USA). Other chemicals used were all of the highest purity commercially available.
Ovariectomy (OVX) and analysis of skeletal morphology
This study was carried out in compliance with the Guideline for Animal Experimentation at Kanazawa University with an effort to minimize the number of animals used and their suffering. Eight-week-old female ddY mice were subjected to OVX or a sham operation as described previously (18) . Mice were killed by decapitation 28 days after OVX, followed by dissection of femurs and subsequent removal of adhering muscles around the bone. Bones were subjected to removal of bone marrows by flashing out with phosphate-buffered saline (PBS) and freezing in liquid nitrogen for homogenization. Total RNA and proteins were isolated from these homogenates. Von Kossa staining was also carried out using spinal columns excised from mice 28 days after sham or OVX operation. Spinal columns were fixed in 70% ethanol, embedded in glycolmethacrylate, and sectioned in 7-μm sections. The specimens were observed under a light microscope with a micrometer for calculation of the ratio of bone volume over tissue volume (BV/TV) by ImageJ software (NIH, Bethesda, MD, USA).
Culture of MC3T3-E1 cells
Mouse pre-osteoblastic cell line MC3T3-E1 cells were plated at a density 2.5 × 10 3 cells/cm 2 in αMEM containing 10% fetal bovine serum (FBS) in appropriate dishes and then cultured at 37°C for different periods up to 21 days under 5% CO 2 with or without 50 μg/ml ascorbate and 5 mM β-glycerophosphate, which are both required for osteoblastic differentiation. Medium was changed every 3 days.
Establishment of stable transfectants
Pre-osteoblastic MC3T3-E1 cells were plated at a density of 1.5 × 10 5 cells/cm 2 . After 24 h, cells were stably transfected with either pcDNA3.1 vector linked to the full-length coding regions of the xCT subunit (MC3T3-xCT) or pcDNA3.1 alone (MC3T3-EV) as an empty vector (EV) using 2 μg of DNA and Lipofectamine and Plus reagent in 10 ml of medium. After 24 h, and every 48 h thereafter for 2 weeks, culture medium was replaced with fresh medium containing 600 μg/ml of G418. Pools of 15 clones of cells were isolated for further studies. Pools of clones between passages 2 and 5 were used for subsequent experiments. In 2 different MC3T3-xCT clones, such as xCT #1 and xCT #5, cultured for 5 days in the absence of differentiation inducers, marked increases were invariably seen in the reducing activity of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide as a cell viability index (19) : EV = 45.7 ± 0.1; xCT #1 = 63.3 ± 0.7**; xCT #5 = 55.2 ± 0.21**, P < 0.01], respectively. In these stable transfectants cultured for 5 days in the absence of inducers, moreover, no cells reactive to dihydrodichlorofluorescein diacetate used for the detection of reactive oxygen species (ROS) were found irrespective of the transfection with xCT expression vector (data not shown).
Reverse transcription polymerase chain reaction (RT-PCR) analysis
Cultured cells were superficially washed with PBS twice, followed by extraction of total RNA using ISOGEN according to the standard manufacturer's instructions and subsequent synthesis of cDNA with 25 ng/ ml oligo (dT)18 primer, 0.5 mM dNTP mix, and MMLV Reverse Transcriptase. The reverse transcriptase reaction was run at 37°C for 50 min with bone and cell extracts, and an aliquot of synthesized cDNA was directly used for PCR performed in buffer containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 200 mM each of dNTP, 20 pmol of each primer, and 2 U of Taq DNA polymerase as reported elsewhere (20) . Reactions were initiated by the incubation at 94°C for 5 min, and PCR (denaturation at 94°C for 1 min, annealing at 64°C for 1 min, and extension at 72°C for 1 min, respectively) was performed for 28 cycles with a final extension at 72°C for 10 min. Electrophoresis was run for an aliquot of PCR amplification products on a 2% (w/v) agarose gel, followed by detection of DNA with ethidium bromide. Appropriate PCR DNA products were extracted from agarose gel using DNA extraction spin columns, followed by sequencing by ABI Prism 310 Genetic Analyzer (Perkin-Elmer, Boston, MA, USA) using a cycle sequencing kit. In preliminary experiments, a clearly linear correlation was optimized with each primer set, respectively. Quantitative analysis was done at the cycle number with high linearity between mRNA expression and cDNA production using primers for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). PCR products were quantified by using a densitograph, followed by calculation of ratios of expression of mRNA for each gene over that for GAPDH (21) .
Western blotting analysis
Bones and cultured cells were individually homogenized in 20 mM Tris-HCl buffer (pH 7.5) containing protease inhibitors, followed by centrifugation at 4°C for 30 min at 100,000 × g as described elsewhere (17) . Pellets thus obtained were dissolved in 10 mM Tris-HCl buffer containing 2% sodium dodecylsulfate (SDS) and 5% 2-mercaptoethanol, followed by boiling for 10 min and subsequent loading of an aliquot for electrophoresis on a 10% SDS-polyacrylamide gel, followed by blotting to a polyvinylidene fluoride membrane. After blocking by 5% skim milk dissolved in 20 mM Tris-HCl buffer (pH 7.5) containing 137 mM NaCl and 0.05% Tween 20 (TBST), the membrane was incubated with one of the antibodies against Runx2, β-tubulin, and xCT adequately diluted with TBST containing 1% skim milk and then with the horseradish peroxidase-conjugated secondary antibody conjugated. Finally, the membrane was incubated with ECL TM detection reagent to detect immunoreactive proteins, followed by exposure to X-ray films for different periods to obtain films appropriate for subsequent quantitative densitometry.
Determination of Ca
2+ accumulation Cells were washed twice with PBS and then sonicated in 0.1 M Tris-HCl buffer (pH 7.5) containing 0.1% Triton X-100. Hydrochloric acid at 6 M was added to these cell lysates to make a final concentration of 2 M HCl. Following the incubation for 16 -24 h at room temperature, cell lysates were centrifuged at 20,000 × g for 5 min, and Ca 2+ accumulation was determined in the supernatant by using a C-TEST kit (22) .
Luciferase reporter assay
Cbfa1 promoter (P1 promoter of type 2 Runx2) fragments with different lengths of −89/+111 and −976/+111 bp (23) were kindly provided by Dr. P. Ducy (Baylor College of Medicine, Houston, TX, USA). Both −345/+111 and −524/+111 Cbfa1 promoter fragments were prepared from the −976/+111 Cbfa1 promoter fragment by PCR using the following primers: 5′-CCATGG AGGCCTTACCACAAGCCTTT-3′ as −345/+111 upstream primer, 5′-CCATGGAAAAAGCAGAGGAGGG AAGG-3′ as −524/+111 upstream primer, and 5′-TCTTT ATGTTTTTGGCGTCT-3′ as a downstream primer in our laboratory. The PCR-amplified DNA products were cloned into the pGL3-basic. Cells were seeded at 1.25 × 10 4 cells/cm 2 and maintained at 37°C in a humidified 5% CO 2 incubator. The DNA transfection of 0.4 μg DNA with an internal control vector phRL-SV40 to cells was performed by the lipofection method using Lipofectamine/Plus reagent for 24 h after cell seeding. Medium was replaced with αMEM containing 10% FBS after transfection, followed by exposure to a test drug for 48 h. Firefly and Renilla luciferase activities were determined using the Dual Luciferase Assay system. MC3T3-E1 cells were seeded at 1.25 × 10 4 cells/cm 2 in 24-well plates. After 24 h, they were transiently transfected with pcDNA3.1 vector containing the full-length coding region of the xCT subunit using 0.4 μg of DNA and Lipofectamine Plus reagent (Invitrogen) for 1 h in Opti-MEM.
Data analyses
Results are all expressed as the mean ± S.E.M. and the statistical significance was determined by the two-tailed and unpaired Student's t-test or the one-way analysis of variance ANOVA with the Bonferroni/Dunnett post hoc test as described previously (19) .
Results
Upregulation of xCT expression in ovariectomized mouse femurs
To evaluate the possible functional significance of the Xc − system in bone remodeling in vivo, we conducted OVX in mice as an animal model of postmenopausal osteoporosis. OVX drastically decreased uterine weight at 28 days after operation without markedly affecting body weight (data not shown), while OVX induced a marked reduction of Von Kossa staining in spinal columns (Fig. 1A) . Quantification of these data clearly revealed a significant decrease in the ratio of BV/TV (Fig.  1B) . In femurs of these ovariectomized mice with a typical osteoporotic symptom, significant downregulation was seen with expression of mRNA (Fig. 1C) and the corresponding protein (Fig. 1D) for the master regulator of osteoblastogenesis Runx2 when compared with that in sham-operated mice. By contrast, OVX significantly increased the endogenous levels of mRNA ( Fig. 2A ) and corresponding protein (Fig. 2B) for the antiporter xCT subunit by 2-fold in femurs 28 days after operation. Therefore, the xCT subunit would be indeed responsive to in vivo environmental stress relevant to the pathogen- esis and/or the etiology of postmenopausal osteoporosis along with Runx2.
Stable xCT transfection
To elucidate the role of Xc − in osteoblastic differentiation in vitro, osteoblastic MC3T3-E1 cells were stably transfected with pcDNA3.1 containing the full-length coding region of the xCT subunit for subsequent culture with differentiation inducers such as ascorbate and β-glycerophosphate. An almost 4-fold increase was seen in xCT mRNA expression in different clones from #1 to #5 of MC3T3-E1 cells stably transfected with xCT expression vector on RT-PCR analysis, while Western blotting analysis revealed a more than 2-fold increase in xCT protein levels in the clones #1 and #5 compared to MC3T3-EV cells [xCT protein (%): EV = 100 ± 12; xCT #1 = 312 ± 16**; xCT #5 = 208 ± 21**, P < 0.01]. A marked increase was found in the endogenous levels of the Xc − product GSH in both MC3T3-xCT #1 and MC3T3-xCT #5 clones [GSH (nmol/mg protein): EV = 22.4 ± 0.5; xCT #1 = 41.9 ± 2.2**; xCT #5 = 31.4 ± 0.8**, P < 0.01], whereas temperature-dependent [
14 C] cystine accumulation was significantly increased in stable xCT transfectants {[
14 C]cystine accumulation (pmol/mg protein per 20 min): EV = 228.0 ± 1.6; xCT #1 = 317.1 ± 5.3**, P < 0.01}. Accordingly, subsequent experiments were done using clones #1 and #5 as stable transfectants of the xCT subunit.
Stable xCT transfectants were cultured in αMEM in the presence of differentiation inducers such as ascorbate and β-glycerophosphate for different periods up to 21 days for determination of osteoblastic marker gene expression. In both stable xCT transfectants, no marked nodule formation was found in contrast to stable EV transfectants (Fig. 3A) . Calcium accumulation was markedly increased in proportion to the duration of culturing up to 21 days in MC3T3-EV cells, but not detectable in both stable xCT transfectants (Fig. 3B) . Expression of mRNA was increased for osteoblastic maturation markers, such as alkaline phosphatase (ALP) and osteocalcin, in proportion to increasing culture periods in MC3T3-EV cells from 7 to 21 days, while stable xCT overexpression invariably led to a significant decrease in mRNA expression of both ALP (Fig. 3C) and osteocalcin (Fig. 3D) throughout the culture period. Accordingly, stable overexpression of the xCT subunit could lead to suppressed osteoblastic differentiation in MC3T3-E1 cells.
Runx2 expression in stable xCT transfectants
Stable transfectant cells were next cultured in the presence of ascorbate and β-glycerophosphate for promotion of osteoblastic differentiation, followed by determination of mRNA and protein expression of the master regulator of osteoblastogenesis Runx2. In both stable xCT transfectant clones cultured for 7 days, a significant decrease was invariably seen in mRNA (Fig. 4A ) and the corresponding protein (Fig. 4B ) expression for Runx2 compared with that in stable EV transfectants.
Runx2 promoter activity
In order to evaluate the underlying mechanism, MC3T3-E1 cells were cultured for 1 day in the absence of differentiation inducers, followed by transient transfection with xCT expression vector and luciferase re- 4 . Downregulation of Runx2 expression in stable xCT transfectants. Stable transfectant cells were cultured in the presence of ascorbate and β-glycerophosphate for 7 days, followed by determination of expression of mRNA (A) and corresponding protein (B) for Runx2. Each value is the mean ± S.E.M. in 3 independent experiments. *P < 0.05, **P < 0.01, significantly different from each control value obtained in MC3T3-EV cells. (Fig. 5A) . Stable transfectant cells were similarly cultured for determination of Runx2 promoter activity using a reporter plasmid with different lengths of Runx2 promoter region. In MC3T3-xCT #1 cells transfected with Runx2 promoter plasmid with a construct of −976/+111 bp upstream and cultured in the presence of inducers for 2 days, a significant decrease was seen in luciferase activity compared with that in MC3T3-EV cells (Fig. 5B) . Therefore, transient and stable overexpression of xCT subunit could invariably inhibit transactivation of Runx2 gene toward reduced expression of corresponding mRNA and protein in MC3T3-E1 cells under differentiation.
Runx2
Identification of cis-element on Runx2 promoter
To identify the responsive upstream regions of Runx2 promoter, MC3T3-E1 cells cultured for 1 day were transiently transfected with the luciferase reporter plasmid linked to Runx2 promoter fragments with different lengths from −976 to −89 bp upstream in either the presence or absence of xCT expression vector, followed by further culture in the presence of differentiation inducers for an additional 2 days and subsequent cell harvest for determination of the luciferase activity. In cells cotransfected with EV, luciferase activity was gradually decreased in proportion to the deletion of Runx2 promoter constructs from −976 to −89 bp upstream (Fig.  6A) . In cells co-transfected with xCT expression vector, however, a significant decrease was only seen with Runx2 promoter of −976 bp upstream, but not with Runx2 promoter fragments of −524 to −89 bp upstream. These results suggest that the responsive cis-element would be an AP-1 site located between −976 and −524 bp upstream on the Runx2 promoter region.
To further confirm this possibility, MC3T3-E1 cells were transiently transfected with a luciferase reporter plasmid with 7 tandem AP-1 sites (pAP-1-Luc) or 4 tandem CRE sites (pCRE-Luc) in either the presence or absence of xCT expression vector, followed by further culture with differentiation inducers for an additional 2 days. In cells with the AP-1 plasmid (Fig. 6B ), but not with the CRE plasmid (Fig. 6C) , transient overexpression of xCT led to a significant decrease in luciferase activity. Accordingly, the xCT subunit would play a pivotal role in downregulation of Runx2 expression through the AP-1 site located between −976 and −524 bp upstream of Runx2 promoter regions toward suppressed osteoblastogenesis.
Discussion
The essential importance of the present findings is that mRNA and corresponding protein expression was more than doubled for the xCT subunit of the Xc − along with the decrease in Runx2 mRNA and protein expression in femurs of ovariectomized mice. OVX has been employed to experimentally evaluate model animals with bone loss seen in patients with postmenopausal osteoporosis caused by estrogen deficiency (24) . In ovariectomized animals, osteoblastic indices, such as osteoblast number and osteoblast surface, are increased, as revealed by histomorphometric analysis, in addition to the reduction of bone mineral density (25) . In mesenchymal stem cells isolated from bone of ovariectomized mice, a marked reduction of mRNA expression is seen for a variety of osteoblastic differentiation marker genes, including type I collagen and ALP, in addition to the master regulator of osteoblastogenesis Runx2 (26) . In this study, moreover, cellular maturation was markedly suppressed through downregulation of the expression of both mRNA and corresponding protein for Runx2 in osteoblastic cell line MC3T3-E1 cells with stable overexpression of the xCT subunit. To our knowledge, this is the first direct demonstration of a negative correlation between expression profiles of Runx2 and xCT subunit during osteoblastogenesis in ovariectomized mouse femurs in vivo and in pre-osteoblastic MC3T3-E1 cells in vitro. Although several previous studies including ours have already demonstrated the functional expression of the Xc − in several cells such as chondrocytes (20) , dendritic cells (27) , and meningeal cells (28) , no direct evidence is available for a pivotal role of the Xc − in the cellular differentiation of osteoblas- Intracellular glutathione levels are regulated by the bidirectional Xc − system expressed at the cellular surface as a crucial determinant of the incorporation of extracellular cystine across plasma membranes to fuel the substrate cysteine in exchange for intracellular Glu in a variety of eukaryotic cells (12, 15, 16, 29) . Under the condition of high extracellular Glu levels, however, extracellular Glu is supposed to be taken up in exchange for intracellular cystine through the promoted retrograde operation of the Xc − , followed by decreased intracellular levels of GSH toward cell death mediated by GSH depletion (15, 16) . Although marked apoptosis is induced by extracellular Glu at a high concentration, but not by agonists for any Glu-receptor subtypes, in association with GSH depletion in cultured rat costal chondrocytes (20) , exposure to Glu at a high concentration leads to marked inhibition of cellular proliferation through a mechanism related to GSH depletion without inducing apoptotic cell death in osteoblastic MC3T3-E1 cells (17) . It is thus conceivable that extracellular Glu at a high concentration could induce apoptosis through a mechanism associated with the depletion of intracellular GSH as a consequence of the promoted retrograde operation of the Xc − in chondrocytes, but not in osteoblasts. However, future analysis is inevitably essential on intracellular cystine levels for demonstration of the possible retrograde operation of the Xc − in a particular situation. Taken together, the Xc − could promote proliferation for self-renewal together with inhibition of differentiation through a mechanism related to the synthesis of intracellular GSH during osteoblastogenesis. The exact molecular mechanism as well as the functional and pathological significance, however, remains to be elucidated. It is possible to speculate that intracellular GSH would induce S-glutathionylation of particular transcription factors required for the expression of Runx2 in osteoblastic cells. In HL60 cells, intracellular GSH plays a specific signaling role in redox regulation through Sglutathionylation of a variety of transcription factors, including nuclear factor-κB (NF-κB), heat shock proteins, and AP-1 components, in addition to a role as an endogenous antioxidant (30) . In hepatocytic cell lines such as HepG2 and 3B cells, protein glutathionylation indeed occurs at cytoplasmic p65NF-κB to inhibit cell survival due to the suppression of NF-κB activity (31) . Mass spectroscopy analysis reveals S-glutathionylation of an endoplasmic reticulum protein as an upstream signaling event in the unfolded protein response after the formation of intracellular nitric oxide in HL60 and ovarian cancer cells (32) . In human HepG2 hepatoma cells, S-glutathionylation disturbs different intracellular and extracellular signaling processes mediated by signal transducer and activator of transcription 3 (33) . Moreover, Runx2 expression level is regulated by the cell cycle (34, 35) , as well as degradation through the ubiquitin-proteasome pathway (36) . The possibility that stable xCT overexpression may modulate S-glutathionylation, cell cycle, and/or the ubiquitin-proteasome system for the downregulation of Runx2 expression toward negative regulation of osteoblastogenesis in MC3T3-E1 cells, therefore, is not ruled out.
In accordance with the present findings, a microarray analysis reveals that xCT mRNA expression is up-regulated in cultured femoral osteoblasts prepared from patients suffering from postmenopausal osteoporosis compared with those from non-osteoporotic patients (37) . Although the xCT subunit plays a pivotal role in the biosynthesis of intracellular GSH through promotion of the incorporation of extracellular cystine for intracellular cysteine as a substrate, xCT expression is under the control by the transcription factor nuclear factor erythroid 2-related factor-2 responsible for the regulation of many phase II detoxifying enzymes and oxidative stressinducible proteins in eukaryotic cells exposed to different insults relevant to oxidative stress, including ROS, ionizing radiation, and a variety of chemical entities of electrophile compounds, lipid peroxides, and antioxidants (38 -41) . By contrast, the administration of antioxidants, such as N-acetyl cysteine and ascorbate, increases tissue GSH levels in association with prevention of OVXinduced bone loss, while L-buthionine-(S,R)-sulfoximine, a specific inhibitor of glutathione synthesis, causes substantial bone loss (25) . Male and female xCT-null mice are shown to normally develop with fertility for at least 6 months after birth without any abnormal skeletal phenotypes (42) . These paradoxical data could be accounted for by taking into consideration the possibility that intracellular GSH levels would determine the profile of Sglutathionylation required for the downregulation of Runx2 expression in osteoblasts. OVX would lead to bone loss through a mechanism related to the interference with Runx2 signaling by the xCT subunit up-regulated after the pathological generation of ROS in osteoblasts in a particular situation. It is thus conceivable that estrogen deficiency would promote the generation of ROS toward xCT subunit upregulation after OVX. The final conclusion should await the direct demonstration of S-glutathionylation of different transcription factors required for osteoblastogenesis and/or osteoclastogenesis.
It thus appears that there is a negative correlation between expression profiles of the master regulator of osteoblastogenesis Runx2 and the crucial determinant of GSH synthesis xCT subunit in femurs of ovariectomized mice. The xCT subunit of the Xc − could inhibit cellular differentiation through a mechanism related to the down-regulation of Runx2 expression in osteoblastic cells. Therefore, the Xc − could be a future target molecule for the discovery and development of innovative drugs beneficial for the prophylaxis and/or the treatment of a variety of symptoms seen in patients with postmenopausal osteoporosis.
